Development and early diagnosis of critical illness myopathy in COVID‐19 associated acute respiratory distress syndrome

Background The COVID‐19 pandemic has greatly increased the incidence and clinical importance of critical illness myopathy (CIM), because it is one of the most common complications of modern intensive care medicine. Current diagnostic criteria only allow diagnosis of CIM at an advanced stage, so that...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of cachexia, sarcopenia and muscle Vol. 13; no. 3; pp. 1883 - 1895
Main Authors:	Rodriguez, Belén, Branca, Mattia, Gutt‐Will, Marielena, Roth, Marianne, Söll, Nicole, Nansoz, Sandra, Cameron, David R., Tankisi, Hatice, Tan, S. Veronica, Bostock, Hugh, Raabe, Andreas, Schefold, Joerg C., Jakob, Stephan M., Z'Graggen, Werner J.
Format:	Journal Article
Language:	English
Published:	Germany John Wiley & Sons, Inc 01.06.2022 John Wiley and Sons Inc Wiley
Subjects:	Anesthesia Biopsy Coronaviruses COVID-19 Disease transmission Drug dosages Electrodes Electromyography Guillain-Barre syndrome ICU‐acquired weakness Illnesses Intensive care Intubation Laboratories Membrane potential Muscle velocity recovery cycle Nerve conduction studies Neuromuscular blocking agents Original Patients Potassium Propofol Respiratory distress syndrome SARS‐CoV‐2 Sepsis Velocity Ventilators Weaning Switzerland Neuromuscular blocking agents ICU-acquired weakness SARS-CoV-2 Sepsis Electromyography Membrane potential Propofol Nerve conduction studies Muscle velocity recovery cycle
ISSN:	2190-5991, 2190-6009, 2190-6009
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!